register

News & Trends - MedTech & Diagnostics

Departing APHA CEO reflects on 24-year tenure and future of private health sector

Health Industry Hub | July 2, 2024 |

MedTech & Diagnostics News: Michael Roff, CEO of the Australian Private Hospitals Association (APHA), who will be departing the organisation on 5th July, reflected on his tenure of 24 years and discussed the future of the private health sector.

Roff highlighted several key achievements during his time as CEO, sharing his proudest moments and the milestones that defined his leadership journey. When asked about decisions he might have made differently, Roff provided thoughtful insights into the complexities of his role and the evolving healthcare landscape.

Looking ahead, Roff envisioned significant changes in the private health sector over the next 10-15 years, focusing on how the sector can unlock greater value for patients.

“Over my time, there’s been a lot of antagonism between hospitals and health insurers. There have been attempts along the way for a more collaborative and cooperative approach both on an industry level and at an individual insurance or hospital level. But it seems that everybody reverts to falling back to their own corners.

“In terms of unlocking value for consumers, the funding model needs to change to allow for private hospitals to provide more out of hospital community care under the auspices and by the staff of the hospitals, so that there is a continuum of care for private sector patients,” he explained.

“There are salient lessons from the banking Royal Commission. You don’t want to get into the same sort of situation in private health, where a patient is being streamed into a particular care pathway, not because it’s in their best clinical interests, but because it’s in the best financial interest of their insurer,” Roff stressed.

He expressed optimism about the potential impact of the new review of private hospitals announced by Federal Health Minister Mark Butler.

“[The Department of Health] is obviously convinced by the data and they acted very quickly. They are undertaking their own data collection and analysis, and at the same time, looking at possible government policy responses,” he stated.

Roff also emphasised the importance of learning from international best practices, identifying key lessons and policies that could benefit the Australian healthcare system.

As he contemplates his legacy, Roff hopes to leave a lasting positive impact on the healthcare industry.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


ESG

Surgeons lead push for $1.5 million hospital sustainability project

Surgeons lead push for $1.5 million hospital sustainability project

Health Industry Hub | October 23, 2024 |

ESG: Australia’s healthcare sector contributes 7% of the country’s total emissions. The Royal Australasian College of Surgeons (RACS) has joined […]

More


News & Trends - MedTech & Diagnostics

AI-assisted colonoscopy boosts polyp and adenoma detection

AI-assisted colonoscopy boosts polyp and adenoma detection

Health Industry Hub | October 23, 2024 |

MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]

More


News & Trends - Pharmaceuticals

'Every day of delay is costing Australian lives', says Rare Cancers Australia CEO

‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO

Health Industry Hub | October 23, 2024 |

Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]

More


News & Trends - Pharmaceuticals

Government's silence on Senate report leaves cancer patients in limbo

Government’s silence on Senate report leaves cancer patients in limbo

Health Industry Hub | October 23, 2024 |

Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]

More


This content is copyright protected. Please subscribe to gain access.